Human AKT2 CRISPR gRNA in Lenti Particles
This is a V-Akt Murine Thymoma Viral Oncogene Homolog 2 plasmid with gRNA insert cloned into Lentiviral VectorpLenti-U6-sgRNA-PGK-Neo. Insert length: not_set. Stable, Transient expression. Suitable for PExp and GEEN.
Bacterial selection: Ampicillin.
Catalog No. ABIN5082653
$1,511.06
Plus shipping costs $50.00, if applicable $20.00 dry ice
3 x 300 μL
Shipping to:
United States
Delivery in 31 to 41 Business Days
Quick Overview for Human AKT2 CRISPR gRNA in Lenti Particles (ABIN5082653)
Gene
AKT2
(V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
Application
Protein Expression (PExp), Genome Editing with Engineered Nucleases (GEEN)
Insert
gRNA
Vector
Lentiviral Vector
Vector Backbone
pLenti-U6-sgRNA-PGK-Neo
Promoter
U6 Promoter, PGK Promoter
Bacterial Resistance
Ampicillin
Expression Type
Stable, Transient
-
-
Species
- Human
-
Purpose
- Set of 3 gRNA against AKT2 in Lentiviral Particles with a Titer of >1x10e7 IU/mL. (Cas9 required separately)
-
Sequence
-
""2 GACAGACACC TCATTCA
134 GGGTAGAGTC TGATCAG
239 GGACCACAGT CATCGAG"" -
Specificity
- GRNAs are designed for use with Cas9 Nuclease only.
-
Components
- Lentiviral particles with a set of 3 gRNAs (3 x 300 μL) covering different sequences of AKT2
-
Selectable Marker
- Neomycin
-
-
-
-
Application Notes
- Recommended for quality control: Restriction Enzyme Digest and Sequencing
-
Restrictions
- For Research Use only
-
-
-
Format
- Viral Particles
-
Storage
- -80 °C
-
Expiry Date
- 12 months
-
-
- AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
-
Alternative Name
- AKT2
-
NCBI Accession
- NM_001626
Target
-
You are here:
